0001011438-12-000170.txt : 20120315
0001011438-12-000170.hdr.sgml : 20120315
20120315133028
ACCESSION NUMBER: 0001011438-12-000170
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111231
FILED AS OF DATE: 20120315
DATE AS OF CHANGE: 20120315
EFFECTIVENESS DATE: 20120315
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Consonance Capital Management LP
CENTRAL INDEX KEY: 0001544773
IRS NUMBER: 260294313
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-14924
FILM NUMBER: 12693266
BUSINESS ADDRESS:
STREET 1: 888 SEVENTH AVENUE
STREET 2: 43RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212.660-8062
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVENUE
STREET 2: 43RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
13F-HR
1
form_13f-consonance.txt
-----------------------------------
OMB APPROVAL
-----------------------------------
OMB Number: 3235-0006
Expires: August 31, 2012
Estimated average burden
hours per response..........22.6
-----------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F
FORM 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: December 31, 2011
Check here if Amendment [ ]; Amendment Number:
This Amendment (Check only one.): [ ] is a restatement.
[ ] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Consonance Capital
Address: 888 Seventh Avenue, 43rd Floor
New York, New York 10019
Form 13F File Number:
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Kevin H. Livingston
Title: Managing Director
Phone: 212-660-8060
Signature, Place, and Date of Signing:
/s/ Kevin H. Livingston New York, New York March 15, 2012
----------------------- ------------------- ------------------
[Signature] [City, State] [Date]
Report Type (Check only one.):
[X] 13F HOLDINGS REPORT.(Check here if all holdings of this reporting manager
are reported in this report.)
[ ] 13F NOTICE. (Check here if no holdings reported are in this report, and
all holdings are reported by other reporting manager(s).)
[ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this
reporting manager are reported in this report and a portion are reported by
other reporting manager(s).)
Form 13F Summary Page
Report Summary:
Number of Other Included Managers: 0
-------
Form 13F Information Table Entry Total: 15
-------
Form 13F Information Table Value Total: $92,584
-------
(thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
No. Form 13F File Number Name
--- -------------------- ----
Consonance Capital
Form 13F Information Table
Quarter ended December 31, 2011
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS or SH/ PUT/ INVE OTH VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISC MAN SOLE SHARED NONE
---------------------------- -------------- --------- --------- --------- --- ---- ---- --- --------- ------ ----
ABAXIS INC COM 002567105 $ 3,154 114,000 SH SOLE 114,000
BIOSCRIP INC COM 09069N108 $ 6,427 1,177,061 SH SOLE 1,177,061
COMPUTER PROGRAMS & SYS INC COM 205306103 $ 5,841 114,274 SH SOLE 114,274
DERMA SCIENCES INC COM PAR $.01 249827502 $ 305 40,216 SH SOLE 40,216
EXPRESS SCRIPTS INC COM 302182100 $ 9,590 214,600 SH SOLE 214,600
JAZZ PHARMACEUTICALS INC COM 472147107 $ 15,977 413,600 SH SOLE 413,600
MEDCATH CORP COM 58404W109 $ 816 111,957 SH SOLE 111,957
MEDICINES CO COM 584688105 $ 4,235 227,200 SH SOLE 227,200
NATUS MEDICAL INC DEL COM 639050103 $ 3,983 422,422 SH SOLE 422,422
OPTIMER PHARMACEUTICALS INC COM 68401H104 $ 4,479 365,946 SH SOLE 365,946
QUESTCOR PHARMACEUTICALS INC COM 74835Y101 $ 15,798 379,952 SH SOLE 379,952
SAGENT PHARMACEUTICALS INC COM 786692103 $ 6,057 288,449 SH SOLE 288,449
SANTARUS INC COM 802817304 $ 6,939 2,096,370 SH SOLE 2,096,370
SHANGPHARMA CORP SPONSORED ADR 81943P104 $ 3,749 515,701 SH SOLE 515,701
WUXI PHARMATECH CAYMAN INC SPONS ADR SHS 929352102 $ 5,234 474,100 SH SOLE 474,100
Total Fair Market Value (in thousands): $ 92,584